PT. Dataindo Inti Swakarsa

          PT. Dataindo Inti Swakarsa
Membership | FAQ | About | Contact | Home 

Indonesia Companies - Indonesia Industry Reports - Indonesia Trade Reports - Indonesia Bilateral Reports
SEARCH  
MEMBER LOGIN    

Products

Latest Updates

Related Reports

Related Indonesia Industry Reports
•C3514 - Pesticide Manufacturing
Company News
Bayer Schering Pharma Strengthens Position in Specialty Care
www.kompas.com, 2007-04-09
After the 17-billion Euro acquisition of Schering Indonesia by Bayer Indonesia, the merged company aims to target the specialty care market. Bayer Schering Pharma Indonesia, a division of Bayer Indonesia, has made an investment of 1.4 billion Euro for research and development. In time, there will be 22 brands of medicine marketed using the Bayer Schering brand, which include Adalat OROS®, Avelox® , Cardio Aspirin® , Glucobay® , Ciproxin XR® , Levitra® , Nebido® , Incidal-OD® , Yasmin® , Diane 35® , Microgynon® , Primolut N® , Angeliq® , Mirena® , Nexavar® , Ventasis® , Betaferon® , Bonefos® , Fludara® , Androcur® , Magnevist® and Ultravist®.
Bayer’s Pesticide Market Increases Slightly by 7 Percent
Bisnis Indonesia, page T7, 2005-07-20
Bayer CropScience, a sub-division of PT Bayer Indonesia, underwent domestic market segment increase of 7 percent for the pesticide market for the first semester of 2005. The not so significant growth is due to the specific nature of the industry. Demands from domestic industries are relatively flat and do not grow as fast as other industries. This is related to volume export that is not as abundant as other countries. Stable growth in this field can be acquired due to good climate, stable political condition and supportive government policies.
 
Bayer Indonesia, PT
Indonesia Company Report
Last Update 6-March-2024
Major Businessline : Pharmaceutical

PT. Dataindo Inti Swakarsa
3rd Floor, Gapura Raya Building
Jl. Bangka Raya No. 4, Pela Mampang Email : info@disb2b.com
Jakarta 12720, Indonesia
Selective Member’s Information US $ Select All
Address 0.66
Telephone number(s) [2] 0.44
Facsimile number(s) [1] 0.44
Email 0.50
Website 0.28
Personnel (Commissioner [2], Director [3]) 2.75
Foreign Affiliate 0.50
Establishment Date 0.77
Tax Number (NPWP) 0.77
Company Liasion (Tanda daftar perusahaan) 0.60
Business Activity 0.44
Legality (Ownership Type, Investment Type) 0.39
Number of employees [7-Jun-10] 0.77
Brands / Trade Mark 0.77
Comodity [17] 42.50
Authorised Capital 3.85
Paid Up Capital 3.85
Banker(s) [3] [18-Sep-08] 2.31
Auditor(s) [1] [13-Sep-07] 1.32
Shareholder(s) [3] 9.90
Number Of Shares 3.30
Share Nominal Value 3.30
Additional Information [7-Jun-10] 0.88
Profit and Loss [2002,2003,2004]
(Net Sales, Cost of Goods Sold, Gross Profit, Operating Expense, Operating Profit (Loss), Other Income (Expense), Profit (Loss) After Tax, Growth)
Balance Sheet [2002,2003,2004]
(Total Assets, Current Assets, Non Current Assets, Other Assets, Total Liabilities, Current Liabilities, Long Term Liabilities, Minority, Shareholder's Equity)
 19.80
Ratios (Times) & Per Share Data [2002,2003,2004]
(PER, PBV, Current Ratio, Debt to Equity, Leverage, Gross Profit Margin, Operating Profit Margin, Net Profit Margin, Inventory Turnover, Total Assets Turnover, ROI, ROE)		 0.77
TOTAL PRICE (US$)(RP)
Price 220.003.630.000
Payment Method
Credit Card
Bank Transfer in US$
Bank Transfer in RP
Buy Now

 
Selective Member`s Discount Price
US$
To become a Selective Member
Register
Report Content
PROFIT AND LOSS 2020 2021 2022
Revenue 13,613,840 13,229,085 15,397,484
Cost of Goods N/A N/A N/A
Gross Profit 13,613,840 13,229,085 15,397,484
Net Profit Before Tax 3,139,711 4,528,733 5,123,618
The data above is sample data only
Balance Sheet (In RP Millions) 2020 2021 2022
Total Assets 133,260,087 149,168,842 150,180,752
Non Current Assets 1,888,511 1,935,151 2,024,748
Other Assets 2,885,953 4,075,426 50,103,265
Cash on Hand in Bank 47,751,808 43,551,174 27,213,874
Placement in other Bank 3,697,885 2,558,909 7,344,934
Notes & Securities 48,516,569 57,691,639 10,714,256
Loans 28,329,341 39,280,369 52,778,750
Total Liabilities 120,634,642 135,243,441 134,333,598
Cash
Minority 776 990 1,268
Total Deposits 118,251,011 131,985,222 129,555,406
Call Money 796,988 672,224 720,321
Notes Issued 252,202 425,039 652,439
Borrowings 219,652 484,127 525,316
Other Liabilities 1,114,013 1,675,839 2,878,848
Shareholder"s Equity 12,625,445 13,925,401 15,847,154
The data above is sample data only